Ambea Past Earnings Performance
Past criteria checks 5/6
Ambea has been growing earnings at an average annual rate of 15%, while the Healthcare industry saw earnings growing at 20.5% annually. Revenues have been growing at an average rate of 5.8% per year. Ambea's return on equity is 12.7%, and it has net margins of 4.3%.
Key information
15.0%
Earnings growth rate
15.2%
EPS growth rate
| Healthcare Industry Growth | 8.1% |
| Revenue growth rate | 5.8% |
| Return on equity | 12.7% |
| Net Margin | 4.3% |
| Next Earnings Update | 12 Feb 2025 |
Recent past performance updates
Recent updates
Is Ambea AB (publ) (STO:AMBEA) Potentially Undervalued?
Nov 08
We Think Ambea's (STO:AMBEA) Profit Is Only A Baseline For What They Can Achieve
Aug 23Most Shareholders Will Probably Find That The CEO Compensation For Ambea AB (publ) (STO:AMBEA) Is Reasonable
May 09Earnings Beat: Ambea AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
May 08Ambea (STO:AMBEA) Is Increasing Its Dividend To SEK1.50
Apr 14We Think Ambea's (STO:AMBEA) Profit Is Only A Baseline For What They Can Achieve
Feb 15Is It Time To Consider Buying Ambea AB (publ) (STO:AMBEA)?
Nov 03Is Ambea (STO:AMBEA) A Risky Investment?
Oct 06Estimating The Fair Value Of Ambea AB (publ) (STO:AMBEA)
Aug 10Here's Why Ambea (STO:AMBEA) Has A Meaningful Debt Burden
Apr 05Ambea (STO:AMBEA) Is Increasing Its Dividend To SEK1.25
Apr 05What Is Ambea AB (publ)'s (STO:AMBEA) Share Price Doing?
Oct 07Here's Why Ambea (STO:AMBEA) Has A Meaningful Debt Burden
Jun 29Ambea (STO:AMBEA) Has Announced A Dividend Of kr1.15
Apr 28Ambea (STO:AMBEA) Has Announced A Dividend Of kr1.15
Apr 12Ambea (STO:AMBEA) Has Announced A Dividend Of kr1.15
Mar 29Ambea (STO:AMBEA) Will Pay A Dividend Of kr1.15
Feb 26Revenue & Expenses Breakdown
How Ambea makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 13,969 | 604 | 1,382 | 0 |
| 30 Jun 24 | 13,769 | 545 | 1,386 | 0 |
| 31 Mar 24 | 13,561 | 496 | 1,427 | 0 |
| 31 Dec 23 | 13,312 | 455 | 1,434 | 0 |
| 30 Sep 23 | 13,126 | 344 | 1,460 | 0 |
| 30 Jun 23 | 12,958 | 330 | 1,498 | 0 |
| 31 Mar 23 | 12,790 | 370 | 1,477 | 0 |
| 31 Dec 22 | 12,635 | 366 | 1,474 | 0 |
| 30 Sep 22 | 12,398 | 308 | 1,378 | 0 |
| 30 Jun 22 | 12,123 | 306 | 1,353 | 0 |
| 31 Mar 22 | 11,831 | 257 | 1,308 | 0 |
| 31 Dec 21 | 11,478 | 237 | 1,260 | 0 |
| 30 Sep 21 | 11,254 | 366 | 1,265 | 0 |
| 30 Jun 21 | 11,074 | 328 | 1,204 | 0 |
| 31 Mar 21 | 10,999 | 343 | 1,216 | 0 |
| 31 Dec 20 | 11,083 | 359 | 1,228 | 0 |
| 30 Sep 20 | 11,122 | 302 | 1,298 | 0 |
| 30 Jun 20 | 11,234 | 307 | 1,364 | 0 |
| 31 Mar 20 | 11,335 | 268 | 1,424 | 0 |
| 31 Dec 19 | 11,040 | 215 | 1,451 | 0 |
| 30 Sep 19 | 9,787 | 211 | 1,384 | 0 |
| 30 Jun 19 | 8,484 | 182 | 1,336 | 0 |
| 31 Mar 19 | 7,125 | 244 | 1,263 | 0 |
| 31 Dec 18 | 6,076 | 295 | 1,218 | 0 |
| 30 Sep 18 | 5,990 | 317 | 1,224 | 0 |
| 30 Jun 18 | 5,937 | 307 | 1,206 | 0 |
| 31 Mar 18 | 5,860 | 253 | 1,140 | 0 |
| 31 Dec 17 | 5,816 | 226 | 1,137 | 0 |
| 30 Sep 17 | 5,763 | 178 | 1,151 | 0 |
| 30 Jun 17 | 5,651 | 148 | 1,122 | 0 |
| 31 Mar 17 | 5,561 | 139 | 1,108 | 0 |
| 31 Dec 16 | 5,335 | 128 | 1,008 | 0 |
| 31 Dec 15 | 4,350 | 3 | 698 | 0 |
| 31 Dec 14 | 4,165 | 46 | 656 | 0 |
Quality Earnings: AMBEA has high quality earnings.
Growing Profit Margin: AMBEA's current net profit margins (4.3%) are higher than last year (2.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMBEA's earnings have grown by 15% per year over the past 5 years.
Accelerating Growth: AMBEA's earnings growth over the past year (75.6%) exceeds its 5-year average (15% per year).
Earnings vs Industry: AMBEA earnings growth over the past year (75.6%) exceeded the Healthcare industry 29.5%.
Return on Equity
High ROE: AMBEA's Return on Equity (12.7%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 23:30 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ambea AB (publ) is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erik Moberg | Berenberg |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Karl Norén | Danske Bank |